PE firm TPG Capital said to mull stake sale in IPO-bound Pathology Asia

PE firm TPG Capital said to mull stake sale in IPO-bound Pathology Asia

Photo from Pathology Asia's website.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter